|
|||||
![]() |
|
Business transformation services company Genpact (NYSE:G) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 6.6% year on year to $1.25 billion. Guidance for next quarter’s revenue was better than expected at $1.26 billion at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $0.88 per share was 3.1% above analysts’ consensus estimates.
Is now the time to buy G? Find out in our full research report (it’s free).
Genpact delivered a positive second quarter, with results surpassing Wall Street’s revenue and non-GAAP profit expectations. Management attributed this outperformance to robust growth in its Advanced Technology Solutions segment, particularly in data and AI-driven services, and a healthy pipeline of large deals. CEO Balkrishan Kalra noted, “Our data and AI pipeline has tripled over the last year, and we are innovating rapidly,” highlighting how early investments in AI-driven process transformation are translating into new client wins and deeper engagements with existing customers.
Looking ahead, Genpact’s raised annual guidance is driven by sustained demand for Advanced Technology Solutions and continued expansion of its AI capabilities. The company expects its shift toward higher-value, non-headcount-based contracts to support both growth and margin improvement. CFO Michael Weiner emphasized, “We are sharing AI productivity gains with our clients, but incremental revenue is coming from expanded scope, increased volumes, and entirely new logos,” indicating confidence in the scalability of current initiatives and a resilient demand environment despite macroeconomic caution.
Management credited solid execution in Advanced Technology Solutions and strategic investments in AI as primary drivers of the quarter’s results, with healthy deal flow and expanding partnerships supporting the improved outlook.
Genpact’s outlook for the next quarter and year centers on accelerating AI-enabled transformation, a shift toward higher-margin services, and disciplined execution amid moderate macroeconomic headwinds.
In the upcoming quarters, the StockStory team will watch (1) whether Advanced Technology Solutions can sustain double-digit growth as generative AI use expands; (2) the pace and profitability of new partnership-driven offerings with major technology vendors; and (3) signs that client demand for non-headcount and outcome-based contracts increases. Continued progress in large deal closures and geographic market expansion will also serve as important markers for execution.
Genpact currently trades at $43.25, up from $41.72 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Sep-11 | |
Sep-08 | |
Sep-08 | |
Sep-05 | |
Sep-03 | |
Sep-01 | |
Aug-29 | |
Aug-28 | |
Aug-27 | |
Aug-26 | |
Aug-21 | |
Aug-21 | |
Aug-20 | |
Aug-19 | |
Aug-18 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite